L
Lingyun Ji
Researcher at University of Southern California
Publications - 124
Citations - 5234
Lingyun Ji is an academic researcher from University of Southern California. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 32, co-authored 111 publications receiving 4135 citations. Previous affiliations of Lingyun Ji include University of Texas MD Anderson Cancer Center & Children's Hospital Los Angeles.
Papers
More filters
Journal ArticleDOI
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh,Olena Morozova,Edward F. Attiyeh,Edward F. Attiyeh,Shahab Asgharzadeh,Shahab Asgharzadeh,Jun S. Wei,Daniel Auclair,Scott L. Carter,Kristian Cibulskis,Megan Hanna,Megan Hanna,Adam Kiezun,Jaegil Kim,Michael S. Lawrence,Lee Lichenstein,Aaron McKenna,Chandra Sekhar Pedamallu,Chandra Sekhar Pedamallu,Alex H. Ramos,Alex H. Ramos,Erica Shefler,Andrey Sivachenko,Carrie Sougnez,Chip Stewart,Adrian Ally,Inanc Birol,Readman Chiu,Richard Corbett,Martin Hirst,Shaun D. Jackman,Baljit Kamoh,Alireza Hadj Khodabakshi,Martin Krzywinski,Allan Lo,Richard A. Moore,Karen Mungall,Jenny Q. Qian,Angela Tam,Nina Thiessen,Yongjun Zhao,Kristina A. Cole,Kristina A. Cole,Maura Diamond,Maura Diamond,Sharon J. Diskin,Sharon J. Diskin,Yael P. Mosse,Yael P. Mosse,Andrew Wood,Andrew Wood,Lingyun Ji,Lingyun Ji,Richard Sposto,Richard Sposto,Thomas C. Badgett,Wendy B. London,Yvonne Moyer,Yvonne Moyer,Julie M. Gastier-Foster,Julie M. Gastier-Foster,Malcolm A. Smith,Jaime M. Guidry Auvil,Daniela S. Gerhard,Michael D. Hogarty,Michael D. Hogarty,Steven J.M. Jones,Eric S. Lander,Stacey Gabriel,Gad Getz,Robert C. Seeger,Robert C. Seeger,Javed Khan,Marco A. Marra,Matthew Meyerson,Matthew Meyerson,John M. Maris +76 more
TL;DR: The authors reported a low median exonic mutation frequency of 0.60 per Mb (0.48 nonsilent) and notably few recurrently mutated genes in high-risk neuroblastoma.
Journal ArticleDOI
A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan
Sebastian Brandhorst,In Young Choi,Min Wei,Chia-Wei Cheng,Sargis Sedrakyan,Gerardo Navarrete,Louis Dubeau,Li Peng Yap,Ryan Park,Manlio Vinciguerra,Stefano Di Biase,Hamed Mirzaei,Mario G. Mirisola,Patra Childress,Lingyun Ji,Susan Groshen,Fabio Penna,Patrizio Odetti,Laura Perin,Peter S. Conti,Yuji Ikeno,Brian K. Kennedy,Pinchas Cohen,Todd E. Morgan,Tanya B. Dorff,Valter D. Longo +25 more
TL;DR: It is shown that alternating PF and nutrient-rich medium extended yeast lifespan independently of established pro-longevity genes and decreased risk factors/biomarkers for aging, diabetes, cardiovascular disease, and cancer without major adverse effects, providing support for the use of FMDs to promote healthspan.
Journal ArticleDOI
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Richard H. Ko,Lingyun Ji,Phillip Barnette,Bruce Bostrom,Raymond J. Hutchinson,Elizabeth A. Raetz,Nita L. Seibel,Clare J. Twist,Elena Eckroth,Richard Sposto,Paul S. Gaynon,Mignon L. Loh +11 more
TL;DR: A retrospective cohort review of patients with relapsed and refractory ALL previously treated at TACL institutions between the years of 1995 and 2004 yielded data that may allow useful modeling of an expected remission rate for any population of patients who experience relapse.
Journal ArticleDOI
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh,Jill Salo,Lingyun Ji,André Oberthuer,Matthias Fischer,Frank Berthold,Michael D. Hadjidaniel,Cathy W. Y. Liu,Leonid S. Metelitsa,Roger Pique-Regi,Peter K. Wakamatsu,Judith G. Villablanca,Susan G. Kreissman,Katherine K. Matthay,Hiroyuki Shimada,Wendy B. London,Richard Sposto,Robert C. Seeger +17 more
TL;DR: Interactions between tumor and inflammatory cells may contribute to the clinical metastatic neuroblastoma phenotype, improve prognostication, and reveal novel therapeutic targets.
Journal ArticleDOI
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Girish Dhall,Howard Grodman,Lingyun Ji,Stephen A. Sands,Sharon Gardner,Ira J. Dunkel,Geoffrey McCowage,Blanca Diez,Jeffrey C. Allen,Anjali Gopalan,Albert Cornelius,Amanda Termuhlen,Minnie Abromowitch,Richard Sposto,Jonathan L. Finlay +14 more
TL;DR: To determine the survival of infants and young children with non‐metastatic medulloblastoma using intensive myeloablative chemotherapy and autologous hematopoietic progenitor cell rescue (AuHCR).